Metformin inhibits leptin secretion via a mitogen-activated protein kinase signalling pathway in brown adipocytes

Journal of Endocrinology

Volumn 183, Issue 2, 2004, Pages 299-307

  Klein, Johannes ^c   Westphal, Sören ^c   Kraus, Daniel ^c   Meier, Britta ^c   Perwitz, Nina ^c   Ott, Volker ^c   Fasshauer, Mathias ^a   Klein, H Harald ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANOREXIGENIC AGENT; ANTIDIABETIC AGENT; JANUS KINASE; LEPTIN; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT PROTEIN; STAT3 PROTEIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; DRUG MECHANISM; DRUG TARGETING; ENERGY; ENERGY BALANCE; ENERGY METABOLISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HOMEOSTASIS; HORMONE RELEASE; INSULIN RESISTANCE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; THERMOGENESIS;

ADIPOCYTES; ADIPOSE TISSUE, BROWN; ANIMALS; BLOTTING, WESTERN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOGLYCEMIC AGENTS; LEPTIN; METFORMIN; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; STIMULATION, CHEMICAL;

EID: 9444277280     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.05646     Document Type: Article

References (52)

1. Argaud D, Roth H, Wiernsperger N & Leverve XM 1993 Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes. European Journal of Biochemistry 213 1341-1348.
2. Bailey CJ & Turner RC 1996 Metformin. New England Journal of Medicine 334 574-579.
3. Bray GA & Greenway FL 1999 Current and potential drugs for treatment of obesity. Endocrine Reviews 20 805-875.
4. Ciaraldi TP, Kong AP, Chu NV, Kim DD, Baxi S, Loviscach M, Plodkowski R, Reitz R, Caulfield M, Mudaliar S & Henry RR 2002 Regulation of glucose transport and insulin signalling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects. Diabetes 51 30-36.
5. Danforth E Jr & Himms-Hagen JH 1997 Obesity and diabetes and the beta-3 adrenergic receptor. European Journal of Endocrinology 136 362-365.
6. DeFronzo RA & Goodman AM 1995 Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. New England Journal of Medicine 333 541-549.
7. DeFronzo RA, Barzilai N & Simonson DC 1991 Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. Journal of Clinical Endocrinology and Metabolism 73 1294-1301.
8. Dominguez LJ, Davidoff AJ, Srinivas PR, Standley PR, Walsh MF & Sowers JR 1996 Effects of metformin on tyrosine kinase activity, glucose transport, and intracellular calcium in rat vascular smooth muscle. Endocrinology 137 113-121.
9. Fogelholm M, Valve R, Kukkonen-Harjula K, Nenonen A, Hakkarainen V, Laakso M & Uusitupa M 1998 Additive effects of the mutations in the beta3-adrenergic receptor and uncoupling protein-1 genes on weight loss and weight maintenance in Finnish women. Journal of Clinical Endocrinology and Metabolism 83 4246-4250.
10. Freemark M & Bursey D 2001 The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 107 E55.
11. Friedman JM 2002 The function of leptin in nutrition, weight, and physiology. Nutrition Reviews 60 S1-S14
12. Friedman JM & Halaas JL 1998 Leptin and the regulation of body weight in mammals. Nature 395 763-770.
13. Fruehwald-Schultes B, Oltmanns KM, Toschek B, Sopke S, Kern W, Born J, Fehm HL & Peters A 2002 Short-term treatment with metformin decreases serum leptin concentration without affecting body weight and body fat content in normal-weight healthy men. Metabolism 51 531-536.
14. Fumeron F, Durack-Bown I, Betoulle D, Cassard-Doulcier AM, Tuzet S, Bouillaud F, Melchior JC, Ricquier D & Apfelbaum M 1996 Polymorphisms of uncoupling protein (UCP) and beta 3 adrenoreceptor genes in obese people submitted to a low calorie diet. International Journal of Obesity and Related Metabolic Disorders 20 1051-1054.
15. Glueck CJ, Fontaine RN, Wang P, Subbiah MT, Weber K, Illig E, Streicher P, Sieve-Smith L, Tracy TM, Lang JE & McCullough P 2001 Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism 50 856-861.
16. Guler S, Cakir B, Demirbas B, Gursoy G, Serter R & Aral Y 2000 Leptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 2 313-316.
17. Hawley SA, Gadalla AE, Olsen GS & Hardie DG 2002 The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51 2420-2425.
18. Kirpichnikov D, McFarlane SI & Sowers JR 2002 Metformin: an update. Annals of Internal Medicine 137 25-33.
19. Klaus S 2004 Adipose tissue as a regulator of energy balance. Current Drug Targets 5 241-250.
20. Klein J, Fasshauer M, Ito M, Lowell BB, Benito M & Kahn CR 1999 Beta(3)-adrenergic stimulation differentially inhibits insulin signalling and decreases insulin-induced glucose uptake in brown adipocytes. Journal of Biological Chemistry 274 34795-34802.
21. Klein J, Fasshauer M, Benito M & Kahn CR 2000 Insulin and the beta3-adrenoceptor differentially regulate uncoupling protein-1 expression. Molecular Endocrinology 14 764-773.
22. Klein J, Fasshauer M, Klein HH, Benito M & Kahn CR 2002 Novel adipocyte lines from brown fat: a model system for the study of differentiation, energy metabolism, and insulin action. Bioessays 24 382-388.
23. Kraus D, Fasshauer M, Ott V, Meier B, Jost M, Klein HH & Klein J 2002 Leptin secretion and negative autocrine crosstalk with insulin in brown adipocytes. Journal of Endocrinology 175 185-191.
24. Kumar N & Dey CS 2002 Metformin enhances insulin signalling in insulin-dependent and -independent pathways in insulin resistant muscle cells. British Journal of Pharmacology 137 329-336.
25. Large V & Beylot M 1999 Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin. Diabetes 48 1251-1257.
26. Lowell BB & Flier JS 1997 Brown adipose tissue, beta 3-adrenergic receptors, and obesity. Annual Review of Medicine 48 307-316.
27. Lowell BB & Bachman ES 2003 Beta-adrenergic receptors, diet-induced thermogenesis, and obesity. Journal of Biological Chemistry 278 29385-29388.
28. Mannucci E, Ognibene A, Cremasco F, Bardini G, Mencucci A, Pierazzuoli E, Ciani S, Messeri G & Rotella CM 2001 Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects. Diabetes Care 24 489-494.
29. Matthaei S, Hamann A, Klein HH, Benecke H, Kreymann G, Flier JS & Greten H 1991 Association of metformin's effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes. Diabetes 40 850-857.
30. Matthaei S, Reibold JP, Hamann A, Benecke H, Haring HU, Greten H & Klein HH 1993 In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes. Endocrinology 133 304-311.
31. Matthaei S, Stumvoll M, Kellerer M & Haring HU 2000 Pathophysiology and pharmacological treatment of insulin resistance. Endocrine Reviews 21 585-618.
32. Meuillet EJ, Wiernsperger N, Mania-Farnell B, Hubert P & Cremel G 1999 Metformin modulates insulin receptor signalling in normal and cholesterol-treated human hepatoma cells (HepG2). European Journal of Pharmacology 377 241-252.
33. Mueller WM, Stanhope KL, Gregoire F, Evans JL & Havel PJ 2000 Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes. Obesity Research 8 530-539.
34. Oberkofler H, Dallinger G, Liu YM, Hell E, Krempler F & Patsch W 1997 Uncoupling protein gene: quantification of expression levels in adipose tissues of obese and non-obese humans. Journal of Lipid Research 38 2125-2133.
35. Pedersen O, Nielsen O, Bak J, Richelsen B, Beck-Nielsen H & Sorensen N 1989 The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes. Diabetic Medicine 6 249-256.
36. Porras A, Alvarez AM, Valladares A & Benito M 1998 p42/p44 mitogen-activated protein kinases activation is required for the insulin-like growth factor-I/insulin induced proliferation, but inhibits differentiation, in rat fetal brown adipocytes. Molecular Endocrinology 12 825-834.
37. Radziuk J, Zhang Z, Wiernsperger N & Pye S 1997 Effects of metformin on lactate uptake and gluconeogenesis in the perfused rat liver. Diabetes 46 1406-1413.
38. Rajala MW & Scherer PE 2003 Minireview: The adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144 3765-3773.
39. Rouru J, Koulu M, Peltonen J, Santti E, Hanninen V, Pesonen U & Huupponen R 1995 Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa /fa) Zucker rats. British Journal of Pharmacology 115 1182-1187.
40. Sarabia V, Lam L, Burdett E, Leiter LA & Klip A 1992 Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. Journal of Clinical Investigation 90 1386-1395.
41. Sivitz WI, Wayson SM, Bayless ML, Larson LF, Sinkey C, Bar RS & Haynes WG 2003 Leptin and body fat in type 2 diabetes and monodrug therapy. Journal of Clinical Endocrinology and Metabolism 88 1543-1553.
42. Spiegelman BM & Flier JS 2001 Obesity and the regulation of energy balance. Cell 104 531-543.
43. Stith BJ, Goalstone ML, Espinoza R, Mossel C, Roberts D & Wiernsperger N 1996 The antidiabetic drug metformin elevates receptor tyrosine kinase activity and inositol 1,4,5-trisphosphate mass in Xenopus oocytes. Endocrinology 137 2990-2999.
44. Stith BJ, Woronoff K & Wiernsperger N 1998 Stimulation of the intracellular portion of the human insulin receptor by the antidiabetic drug metformin. Biochemical Pharmacology 55 533-536.
45. Tiraby C & Langin D 2003 Conversion from white to brown adipocytes: a strategy for the control of fat mass? Trends in Endocrinology and Metabolism 14 439-441.
46. Tiraby C, Tavernier G, Lefort C, Larrouy D, Bouillaud F, Ricquier D & Langin D 2003 Acquirement of brown fat cell features by human white adipocytes. Journal of Biological Chemistry 278 33370-33376.
47. Uehara MH, Kohlmann NE, Zanella MT & Ferreira SR 2001 Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension. Diabetes, Obesity and Metabolism 3 319-325.
48. Valve R, Heikkinen S, Rissanen A, Laakso M & Uusitupa M 1998 Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on basal metabolic rate in obese Finns [see comments]. Diabetologia 41 357-361.
49. Wiernsperger NF & Bailey CJ 1999 The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs 38 (Suppl 1) 31-39; discussion 75-82.
50. Yang X, Enerback S & Smith U 2003 Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Obesity Research 11 1182-1191.
51. Yki-Jarvinen H, Nikkila K & Makimattila S 1999 Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus. Drugs 58 (Suppl 1) 53-54; discussion 75-82.
52. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ & Moller DE 2001 Role of AMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation 108 1167-1174.